439 related articles for article (PubMed ID: 24806581)
1. Significance and therapeutic value of miRNAs in embryonal neural tumors.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Molecules; 2014 May; 19(5):5821-62. PubMed ID: 24806581
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Int J Mol Sci; 2014 Nov; 15(11):21554-86. PubMed ID: 25421247
[TBL] [Abstract][Full Text] [Related]
3. Embryonal Tumors of the Central Nervous System: An Update.
Blessing MM; Alexandrescu S
Surg Pathol Clin; 2020 Jun; 13(2):235-247. PubMed ID: 32389264
[TBL] [Abstract][Full Text] [Related]
4. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
5. Aggressive infantile embryonal tumors.
MacDonald TJ
J Child Neurol; 2008 Oct; 23(10):1195-204. PubMed ID: 18952586
[TBL] [Abstract][Full Text] [Related]
6. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
Cole BL; Pierson CR
Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors.
Hsieh TH; Chien CL; Lee YH; Lin CI; Hsieh JY; Chao ME; Liu DJ; Chu SS; Chen W; Lin SC; Ho DM; Liu RS; Lin CH; Wong TT; Wang HW
Carcinogenesis; 2014 Oct; 35(10):2164-74. PubMed ID: 24832085
[TBL] [Abstract][Full Text] [Related]
9. Embryonal Tumors of the Central Nervous System: The WHO 2016 Classification and New Insights.
Pinheiro JAF; de Almeida JCM; Lopes JMPB
J Pediatr Hematol Oncol; 2021 Apr; 43(3):79-89. PubMed ID: 32925406
[TBL] [Abstract][Full Text] [Related]
10. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.
MacDonald TJ; Rood BR; Santi MR; Vezina G; Bingaman K; Cogen PH; Packer RJ
Oncologist; 2003; 8(2):174-86. PubMed ID: 12697942
[TBL] [Abstract][Full Text] [Related]
11. LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR).
Korshunov A; Ryzhova M; Jones DT; Northcott PA; van Sluis P; Volckmann R; Koster J; Versteeg R; Cowdrey C; Perry A; Picard D; Rosenblum M; Giangaspero F; Aronica E; Schüller U; Hasselblatt M; Collins VP; von Deimling A; Lichter P; Huang A; Pfister SM; Kool M
Acta Neuropathol; 2012 Dec; 124(6):875-81. PubMed ID: 23161096
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics and Regression Analyses Manifest Tumor-Specific miRNA Expression Dynamics in Pediatric Embryonal Malignancies.
Braoudaki M; Koutsouris DD; Kouris I; Paidi A; Koutsouri G; George Lambrou I
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5834-5837. PubMed ID: 30441662
[TBL] [Abstract][Full Text] [Related]
13. [Germ cell and embryonal tumors].
Reith W; Mühl-Benninghaus R; Simgen A; Yilmaz U
Radiologe; 2014 Aug; 54(8):772-82. PubMed ID: 25119569
[TBL] [Abstract][Full Text] [Related]
14. Mouse models of CNS embryonal tumors.
Momota H; Holland EC
Brain Tumor Pathol; 2009; 26(2):43-50. PubMed ID: 19856214
[TBL] [Abstract][Full Text] [Related]
15. Embryonal tumors with multi-layered rosettes: a disease of dysregulated miRNAs.
Raghuram N; Khan S; Mumal I; Bouffet E; Huang A
J Neurooncol; 2020 Oct; 150(1):63-73. PubMed ID: 33090313
[TBL] [Abstract][Full Text] [Related]
16. Primitive neuroectodermal tumors of the central nervous system.
Becker LE; Hinton D
Hum Pathol; 1983 Jun; 14(6):538-50. PubMed ID: 6303940
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.
Han YP; Ma CK; Wang SQ; Enomoto A; Zhao Y; Takahashi M; Ma J
J Neurooncol; 2014 Sep; 119(2):343-51. PubMed ID: 24879375
[TBL] [Abstract][Full Text] [Related]
19. MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.
Jaju A; Hwang EI; Kool M; Capper D; Chavez L; Brabetz S; Billups C; Li Y; Fouladi M; Packer RJ; Pfister SM; Olson JM; Heier LA
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1796-1803. PubMed ID: 31601576
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of cyclin A and B1 in pediatric embryonal tumors.
Moschovi M; Alexiou GA; Patereli A; Stefanaki K; Doussis-Anagnostopoulou I; Stofas A; Sfakianos G; Prodromou N
J Neurooncol; 2011 Jul; 103(3):699-704. PubMed ID: 21069428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
